In previous studies, we developed serum-free, bovine pituitary extract (BPE)-free culture conditions for the growth of normal and neoplastic rat mammary epithelial cells. The present studies were aimed at determining if these culture methods could be used to study the influence of specific growth factors on the proliferative potential of normal human mammary epithelial (HME) cells and cells derived from human breast cancer (HBC) specimens. Our results indicate that normal HME cells in primary culture express stringent requirements for insulin (IN), epidermal growth factor (EGF), and cholera toxin (CT). Of these factors, EGF is most important, with essentially no proliferation taking place in the absence of this factor. By contrast, when cells are grown in serum-free primary culture in the presence of a full complement of growth factors and then subcultured, growth in secondary culture is not influenced by the removal of individual growth factors. Growth in secondary culture in the absence of EGF is mediated by autocrine factors secreted by the cells. However, there is no evidence for autocrine activity that mediates growth in the absence of IN in secondary cultures. Primary culture of HBC cells in serum-free, BPE-free medium revealed two patterns of growth factor requirements. One set of HBC cells expressed identical requirements for IN and EGF in primary culture as normal cells. Likewise, these cells grew in secondary culture in the absence of either factor. The second set of tumors expressed independence of IN for growth in primary culture. These cells grew to confluence in primary culture in the absence of IN and could be subcultured in this medium. All tumor cells examined expressed a requirement for EGF for primary culture growth, whereas none of the HBC cells examined expressed a significant CT requirement. In many cases, growth in the absence of CT exceeded that observed in its presence. Thus, our culture system allows analysis of the growth factor requirements of HME and HBC cells in primary culture. Our results indicate significant differences between HME and HBC cells in this regard. However, the results of secondary culture experiments indicate that the growth factor milieu from which cells are taken can have a profound effect on the requirements for growth factors in culture.
Introduction
There are now many culture systems based on media that support extended growth of human mammary epithelial cells from normal and neoplastic tissues. The first such medium was devel-oped by Stampfer etal. [1] . This medium consists of a combination of serum and growth factor-supplemented fresh medium and conditioned medium obtained from various human cancer cell lines. In this culture medium, normal tissue and human breast cancer derived mammary epithelial cells can be grown in mass culture for one to three passages, and addition of a fibroblast feeder layer growth allows growth at clonal densities [2] .
Culture systems that support growth of normal HME cells have now been significantly refined. Growth of these cells over extended periods has been achieved in a growth factor-supplemented serum-free medium containing BPE. For growth over a few passages, the BPE can be replaced by prolactin (M) and prostagladin E-l, allowing growth of HEM cells in a defined medium [3] . Media designed for growth of HBC cells have also been developed. Peterson and van Deurs [4] reported growth of HBC cells in primary culture in a growth factor-supplemented serum-free medium. More recently, long term growth and serial passage of HBC cells has been reported by Band and Sager [5] using a growth factor-supplemented medium containing both BPE and serum. The emphasis of much of the work performed with the culture systems described above has been on developing conditions suitable for long-term growth of human mammary cells and, whenever possible, establishing cell lines. Consequently, there has been relatively little emphasis placed on the role of individual growth factors on the proliferative potential of the cells in primary and secondary cultures in the absence of the undefined factors present in serum and BPE.
In previous work, we developed culture systems that support extended growth of normal and neoplastic rat mammary epithelial cells under serumfree, BPE-free, conditions [6, 7] . These systems were used to compare directly the proliferative potential and growth factor requirements of normal and neoplastic rat mammary cells [8] . The present studies were designed to determine if the culture methods used to study the proliferative potential of normal and neoplastic rat mammary epithelial cells could be ,~_sed for studies of HME cell growth and to compar~ the growth factor requirements of normal tissue and breast cancer-derived human mammary cells in primary and secondary culture.
Material and methods

Preparation of cells for culture
Normal HME cells were obtained by enzymatic dissociation of normal tissues obtained from reduction mammoplasties or from biopsy specimens. Primary breast cancer specimens were obtained from The University of Michigan Breast Care Center. Enzymatic dissociation of both normal and breast cancer tissue was performed essentially as described previously for rat mammary tissues [9] . Briefly, tissues were minced with scalpels and incubated overnight in type III collagenase (200 units/ml, Worthington Biochemicals, Freehold, N J) in Medium 199 in a shaking water bath at 37 ° C. The cells were collected by centrifugation, washed in fresh Medium 199, and incubated in 0.05% Pronase (Calbiochem, LaJolla, CA) in Medium 199 at 37 ° C. Following the pronase incubation, the cells were pipetted gently to break up large clumps of cells and then washed three times in fresh Medium 199. The number of cells in the suspension was determined by counting isolated nuclei with a Coulter counter as described previously [6] . Epithelial aggregates were either seeded directly into culture or were frozen for future use. Cells were frozen in Medium 199 containing 20% FBS and 5% DMSO and freezing was accomplished using a step-freezer.
Tissue culture conditions HME and HBC cells were plated at 2 x 105 or 5 × 105 cells per 60 mm culture dish. The plates were coated with a type I collagen film (Vitrogen 100, Collagen Corp, Palo Alto, CA) and rinsed with Hank's balanced salt solution just prior to use. The serum-containing medium consisted of Ham's F-12 (Hazelton Biologicals, Lenexa, KS) supplemented with ethanolamine (5 aM), N-2-hydroxyethylpiperazine-2-ethane sulfonic acid (HEPES, 10 mM), IN (5/xg/ml), hydrocortisone (ltxg/ml), EGF (10ng/ml), CT (100ng/ml), M (5/xg/ml), progesterone (P, 100ng/ml), 2% fetal bovine serum (FBS), gentamycin (5/xg/ml), and fungizone (0.5 txg/ml). In the serum-free medium, the FBS was replaced with transferrin (5/xg/ml), bovine serum albumin (lmg/ml), sodium selenite (50ng/ ml), and triiodothyronine (10nM). Cells were maintained in a humidified atmosphere of 90% air and 10% CO2 and were fed three times per week.
Cell growth assays
To measure the proliferative potential of HME and HBC cells in various media in primary culture, cells were seeded into 60 mm dishes and 24 hours later the number of attached cells per dish was determined. The cells were grown for 10 to 12 days with three to four medium changes, and the mean number of cells per dish was determined for each group. Cell counts were performed by isolating nuclei directly from monolayers and counting with a Coulter counter as done previously [9] . For experiments performed in secondary culture, cells were seeded into primary culture and grown for 12 days in the fully growth factor-supplemented serum-free medium. The cells were then sub-cultured and seeded at 105 cells per 60 mm culture dish in growth factorfree medium supplemented with 2% FBS (to allow cell attachment) overnight. The cells were then switched to different serum-free media in which individual growth factors were deleted and grown for an additional 10 days. To measure the influence of the EGF-receptor-antibody EGFR-425 on HME cell growth, cells were grown in primary culture in fully growth factor-supplemented serumfree medium and then switched in secondary culture to EGF-free medium as described above. The cells were grown in EGF-free medium in the presence or absence of EGFR-425.
Conditioned medium was collected from HME cell cultures by growing the cells in secondary culture in the absence of a single factor. When these secondary cultures became confluent, the cells were re-fed with fresh medium, incubated for an Serum-free growth of epithelial cells 223 additional 48 hours, and the media collected. To examine mitogenic activity in conditioned medium obtained from HME cell cultures, the normal human mammary epithelial cell line MCF-10 were used as indicator cells [10] . MCF-10 cells were kindly provided by Dr. Herbert Soule of the Michigan Cancer Foundation. MCF-10 cells were seeded at 105 cells per 35 mm culture dish and grown in serum-free medium supplemented with IN, HC, and EGF, or in medium devoid of IN or EGF and containing conditioned medium obtained from HME cells that were grown in secondary culture in the absence of the same factor.
Immunocytochemistry
To examine cytokeratin expression in HME and HBC cells, cells were grown in primary culture in the fully growth factor-supplemented serum-free medium on collagen-coated coverslips (Lux, Flow Laboratories, McLean VA). The cells were fixed and stored in cold ethanol and stained by indirect immunofluorescence.
Materials
The EGFR-425 antibody was kindly provided by Dr. Donald Buchsbaum of The University of Michigan, and the Tab 
Results
Growth factor requirements of HME cells in primary culture
To examine the influence of individual growth factors on the proliferative potential of normal HME cells in primary culture, epithelial aggregates were obtained by enzymatic dissociation of one reduction mammoplasty specimen and two biopsy specimens that consisted of histologically normal mammary tissue. The cells were plated at low density on collagen-coated 60 mm culture dishes and allowed to attach overnight in HEPES-buffered Ham's F-12 medium supplemented with ethanolamine, hydrocortisone, and 2% FBS (plating medium). The next day, attached cells were washed and switched to serum-free medium supplemented with various growth factor combinations. Also at this time, the number of attached cells in triplicate plates was determined. The cells were grown for 12 days with four medium changes, and the number of cells per dish was determined by counting isolated nuclei. The results of a primary culture deletion experiment performed with cells from the reduction mammoplasty specimen are shown in Fig. 1 . Over the 12 day culture period, growth in the fully growth factor-supplemented serum-free medium was equivalent to that obtained in a similar medium that also contained 2% FBS. Also, deletion of M and P from the medium did not result in any decrease in primary culture growth. By contrast, deletion of CT resulted in an approximately 50% reduction in cell growth, and deletion of either IN or EGF dramatically reduced the proliferative potential of the ceils. Thus, for these HME cells, as for rat mammary epithelial cells [7] and other cultured epithelial cell types [11] [12] [13] [14] , there is a synergistic interaction between IN and EGF in stimulating cell growth.
Although addition of M and P to the complete culture medium did not result in enhanced cell proliferation, these hormones did enhance growth when tested in the absence of either IN or EGF. The data in Fig. 2 show that growth in the absence of IN or EGF was greater in the presence of M and P than in their absence. Thus, under sub-optimal culture conditions, mammogenic hormones do have detectable effects on HME proliferation.
Primary culture deletion experiments were also performed with two biopsy samples that were shown to be histologically normal, and the results of these experiments are given in Figs 3A and B. These results confirm the results of experiments with reduction mammoplasty-derived cells and indicate that both IN and EGF are required for HME cell growth. However, the cells from these two samples exhibited much greater dependence on CT than did the reduction mammoplasty cells. This finding is consistent with results reported previously that indicate sample to sample variability with regard to CT requirements for in vitro growth [15] .
The above results indicate that HME cells respond dramatically to the presence or absence of individual growth factors in primary culture. To determine if the cells respond similarly in secondary cultures, HME cells were plated as described above and grown for 12 days in serum-free medium in the presence of a full complement of factors. The cells were then sub-cultured and grown for seven days in medium devoid of specific factors. The data in Fig. 4 show that the cells exhibited little or no sensitivity to growth factor withdrawal in the first passage. The cells grew as well in the absence as in the presence of CT or EGF. Growth in the absence of IN was reduced in comparison to the other groups, but the fold-increase in cell number was much greater in secondary culture than in primary culture in IN-minus medium. Similar results have been obtained in several experiments employing both normal and HBC-derived cells.
To determine if autocrine growth factor synthesis could account for the lack of growth factor requirements in secondary culture, experiments were performed using the newly developed human mammary epithelial cell line MCF-10 as indicator cells, These Cells can be serially propagated in our serum-free medium and have an absolute requirement for both IN and EGF. For these experiments, HME cells were grown for 12 days in primary culture in fully growth factor-supplemented medium, subcultured, and grown for an additional seven to ten days in medium devoid of either EGF or IN. When these secondary cultures became nearly confluent (after three medium changes), the cells were re-fed with fresh medium and incubated for an additional 48 hours, and these conditioned media were collected. The conditioned media obtained in this way were tested for their ability to support growth of MCF-10 cells in the absence of either IN or EGF (Fig. 5) neutralizing EGF-receptor antibody EGFR-425 [16] . HME cells were grown in primary culture in fully supplemented medium, and then grown in secondary culture in the absence of EGF and in the presence or absence of EGFR-425. The results indicate that growth in the secondary cultures in the absence of EGF is abolished by the EGF-receptor antibody (Fig. 6 ). It has been reported that culture of HME cells results in the synthesis of TGF-alpha by the cells [17] . Therefore, we attempted to measure TGFalpha by radioimmunoassay in conditioned medium obtained from secondary cultures of HME cells. Thus far we have not detected TGF-alpha immunoreactive material in conditioned medium that contains EGF-like bioactivity. Furthermore, growth of HME cells in secondary culture in the absence of EGF was not inhibited by incubation with the TGF-alpha neutralizing antibody (Table  1) , even at concentrations as high as 100/xg/ml (data not shown). Thus, the identity of the EGFlike activity secreted by HME cells remains to be determined. growth of secondary HME cell cultures in the absence of EGF. HME cells were grown in primary culture in fully growth factorsupplemented serum-free medium, subcultured, and grown in secondary culture in the absence of EGF and in the presence or absence of 1/xg/ml EGFR-425.
Growth factor requirements of HBC-derived cells in primary culture
Since primary culture deletion experiments are informative with regard to the growth factor requirements of HME (Fig. 7) . Also presented in Fig. 7 are the results of secondary culture deletion experiments that show the same loss of growth factor sensitivity for HBC cells in the first passage as for normal tissue-derived HME cells. The data obtained from SUM-18 are representative of the second pattern of primary culture growth observed thus far. These cells expressed significant growth potential in primary culture in the absence of IN as well as in the absence of CT (Fig. 8) . Cells derived from these tumors grew to confluence in primary culture in the absence of IN and were of CT, and 5 of 7 specimens grew in the absence of IN. Although the number of tumors examined thus far is small, the five tumors that yielded positive growth in the absence of IN are from patients with low or negative estrogen receptor (ER) and progesterone receptor (PR) levels, and were taken from patients that had locally advanced and/or metastatic disease.
subcultured. This level of growth in IN-free medium is many fold greater than anything that we have observed with normal tissue-derived cells.
The results obtained with the seven primary tumors analysed to date are summarized in Table 1 . It is noteworthy that 5 of 5 specimens tested expressed excellent growth potential in the absence
Cytokeratin expression in proliferating HME and HBC-derived cultures
The culture conditions used in these experiments were originally developed for growth of normal and neoplastic rat mammary epithelial cells and to minimize growth of stromal cells [9] . The HME and HBC cells that grew under these culture conditions exhibited a typical epithelial cell morphology. Furthermore, the majority of HME and HBC cells reacted positively with a broad spectrum antikeratin antiserum, and less than 5% of the cells expressed vimentin detectable by immunofluorescence. In summary, the results indicate that our serumfree primary culture system can be used to analyze the growth factor requirements of normal and primary breast cancer-derived human mammary epithelial cells. Our results also indicate that the requirements of HME cells for growth factors are dramatically influenced by the culture environment, such that first passage cells express markedly different growth factor requirements than do primary cells. Furthermore, cells derived from some primary HBC express altered requirements for IN and CT for growth in primary culture.
Discussion
The results of these experiments indicate that the growth factor requirements of normal and human breast cancer-derived mammary epithelial cells can be compared in serum-free, BPE-free primary culture. The culture medium used for these experiments was originally developed for our studies of growth of normal and neoplastic rat mamary epithelial cells. Although there are many similarities between our medium and those used by other groups for growth of human mammary epithelial cells [3, 5] , there are significant differences. First, we use Ham's F-12 as the basal medium, which in our hands is superior to other formulations, including 50 : 50 mix of F-12 and DMEM. Second, primary and secondary culture growth factor experiments are performed in the absence of either serum or BPE. Indeed, BPE does not improve growth of HME or HBC cells in primary culture in our serum-free medium. Thus, our culture medium most closely resembles the medium developed by Peterson and van Deurs [4] . Our serum-free medium does contain BSA which is not completely defined. The BSA is greater than 99% pure; however, previous studies have shown that fatty acids associated with the BSA are important to the growth potential of the cells [6] . Thus, BSA in the growth medium is important for maintenance of the proper osmotic pressure and as a source of fatty acids. The latter function is physiological, in that fatty acids are toxic in free form and are presented to cells in vivo associated with BSA. There is no evidence that BSA is a source of undefined growth factors, and neither rat nor human mammary epithelial cells express any growth in BSA-containing medium that is not supplemented with exogenous growth factors.
In primary culture, HME cells exhibit sensitivity to individual growth factors. These cells, like many other cultured epithelial cell types, grow rapidly in the presence of IN, HC, EGF, and a cAMP agonist such as CT. Deletion of IN, EGF, or CT results in dramatic loss of growth potential. When the same cells are first grown in the presence of a full complement of factors and then tested for responsiveness to deletion of individual factors, dramatically different results are obtained. HME cells (and HBC cells) grow as well in the absence as in the presence of either EGF or CT in secondary culture. In addition, growth in secondary culture in the absence of IN is much greater than that seen in minus-IN primary cultures. The ability of HME cells to grow in secondary culture in the absence of EGF is mediated by autocrine factors secreted into the medium. By contrast, there is no IN-like activity in conditioned medium obtained from cultures grown in the absence of IN. The results obtained in these experiments are consistent with those obtained in other laboratories that indicate up-regulation of growth factors, growth factor receptors, and protooncogenes upon initiation of primary culture of HME cells [17] [18] [19] .
Primary culture experiments performed with cells obtained from primary breast cancers revealed two patterns of growth factor response. First, all tumors examined thus far grew well in primary culture in the absence of CT. In many cases growth in the absence of CT is greater than that observed in its presence. Second, 5 of 7 tumors examined have expressed good growth in primary culture in the absence of IN. These cells come to confluence in primary culture in minus-IN medium and can be serially propagated in the absence of this factor. These results represent clear differences between the response of HME and HBC cells to growth factors in primary culture. However, the results must be interpreted in light of the data obtained in the secondary culture experiments performed with HME and HBC cells. The ability to grow in primary culture in the absence of individual growth factors may reflect genetic changes important to the neoplastic potential of the HBC cells. Alternatively, this phenotype may be a reflection of the environment from which the HBC cells were obtained. That is, the milieu of the primary tumor may be similar to that of the primary culture environment where growth factors are present. Thus, placing cells in primary culture from such an environment may be akin to starting secondary cultures of normal cells following primary culture in the presence of growth factors. Distinguishing between these two possibilities will provide a significant insight into the factors that drive proliferation of HBC cells in vivo.
Immunocytochemical analysis of cells grown from normal and neoplastic tissues indicates that they are epithelial cells. However, it is much more difficult to state unequivocally that cells grown from breast cancer specimens are indeed neoplastic cells. In an attempt to minimize the presence of normal mammary elements in HBC samples, we have worked with samples taken from patients entering a clinical protocol for locally advanced disease. These patients do not receive mastectomies but rather receive open biopsies for staging purposes. Thus, our laboratory receives tumor pieces from the central areas of large lesions that are sampled on the basis of their gross neoplastic appearance. Since these biopsies are for staging purposes, they are given careful histopathologic evaluation. Therefore, the source of the cells used in these experiments and their altered growth factor requirements in serum-free culture suggest that they are indeed human breast cancer cells. However, further work will be required to demonstrate this unequivocally.
Serum-free growth of epithelial cells
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